Suzhou Zelgen Biopharmaceuticals Co Ltd (688266) — Strategic Asset Allocation Index
Suzhou Zelgen Biopharmaceuticals Co Ltd (688266) has a Strategic Asset Allocation Index of 13.4% as of June 2023. Strategic assets (PP&E of CN¥246.14 Million plus long-term investments of CN¥-) total CN¥246.14 Million, measured against net assets of CN¥1.84 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Suzhou Zelgen Biopharmaceuticals Co Ltd Strategic Asset Allocation Index (2016–2022)
This chart shows how Suzhou Zelgen Biopharmaceuticals Co Ltd's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 13.4%, representing strategic assets of CN¥246.14 Million against net assets of CN¥1.84 Billion CNY. Explore Suzhou Zelgen Biopharmaceuticals Co Ltd operating cash flow efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Suzhou Zelgen Biopharmaceuticals Co Ltd (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Suzhou Zelgen Biopharmaceuticals Co Ltd from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 688266 market cap overview.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 31.4% | CN¥247.09 Million | CN¥247.09 Million | CN¥- | CN¥787.49 Million | ▲ +16.3 pp |
| 2021 | 15.1% | CN¥188.91 Million | CN¥188.91 Million | CN¥- | CN¥1.25 Billion | ▲ +9.7 pp |
| 2020 | 5.4% | CN¥91.03 Million | CN¥91.03 Million | CN¥- | CN¥1.69 Billion | ▼ -71.5 pp |
| 2019 | 76.8% | CN¥56.67 Million | CN¥56.67 Million | CN¥- | CN¥73.75 Million | ▲ +56.6 pp |
| 2018 | 20.2% | CN¥56.98 Million | CN¥56.98 Million | CN¥- | CN¥281.64 Million | ▼ -43.9 pp |
| 2017 | 64.1% | CN¥46.81 Million | CN¥46.81 Million | CN¥- | CN¥73.02 Million | ▲ +31.7 pp |
| 2016 | 32.4% | CN¥35.46 Million | CN¥35.46 Million | CN¥- | CN¥109.44 Million | — |